Pfizer seeks full FDA approval for COVID-19 vaccine

(NEW YORK) -- Pfizer and partner BioNtech announced they are starting the process to seek full Food and Drug Administration approval in the U.S. for their COVID-19 vaccine. Since December, their vaccine has been distributed in the U.S. under an "emergency use authorization," which is... Read More.